China's Fosun Pharmaceutical, a growing drug manufacturing company, is poised to price an initial public offering in Hong Kong on Oct. 22 or Oct. 23, a source told Reuters. According to the company's website, Fosun was formed through the integration of Chongqing Yaoyou Pharmaceuticals and Jiangsu Wanbang Biopharmaceutical and has operations in drug manufacturing, research and marketing. Article